Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $789.42 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ferring Pharmaceuticals Inc. | $341.19 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $207.72 | 6 | $0 (2024) |
| Lilly USA, LLC | $76.47 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $37.61 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $35.83 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $31.12 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $22.82 | 1 | $0 (2023) |
| GRT US Holding, Inc. | $19.16 | 1 | $0 (2021) |
| Novo Nordisk Inc | $17.50 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $206.06 | 12 | AstraZeneca Pharmaceuticals LP ($65.77) |
| 2023 | $437.95 | 6 | Ferring Pharmaceuticals Inc. ($245.09) |
| 2022 | $126.25 | 3 | Ferring Pharmaceuticals Inc. ($96.10) |
| 2021 | $19.16 | 1 | GRT US Holding, Inc. ($19.16) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes | ||||||
| 04/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Respiratory | ||||||
| 11/16/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $121.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/08/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: RESPIRATORY | ||||||
| 03/23/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $123.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/10/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $31.12 | General |
| Category: Cardio-renal | ||||||
| 02/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Diabetes | ||||||
| 12/01/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $96.10 | General |
| 11/18/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Neuroscience | ||||||
| 08/26/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2021 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Pain Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 13 | 23 | $2,760 | $1,168 |
| 2021 | 6 | 181 | 183 | $7,281 | $3,809 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 23 | $2,760 | $1,168 | 42.3% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 45 | 45 | $3,600 | $1,883 | 52.3% |
| 0034A | Fee covid-19 vac 4 res | Office | 2021 | 28 | 28 | $2,240 | $1,172 | 52.3% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 17 | 18 | $1,440 | $753.30 | 52.3% |
| 91300 | Sarscov2 vac 30mcg/0.3ml im | Office | 2021 | 46 | 46 | $0.46 | $0.46 | 100.0% |
| 91303 | Sarscov2 vac ad26 .5ml im | Office | 2021 | 28 | 28 | $0.28 | $0.28 | 100.0% |
| 91301 | Sarscov2 vac 100mcg/0.5ml im | Office | 2021 | 17 | 18 | $0.18 | $0.18 | 100.0% |
About Dr. Roberto Rivera Cordero, M.D
Dr. Roberto Rivera Cordero, M.D is a Primary Care healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2021. The National Provider Identifier (NPI) number assigned to this provider is 1457924003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roberto Rivera Cordero, M.D has received a total of $789.42 in payments from pharmaceutical and medical device companies, with $206.06 received in 2024. These payments were reported across 22 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($789.42).
As a Medicare-enrolled provider, Rivera Cordero has provided services to 194 Medicare beneficiaries, totaling 206 services with total Medicare billing of $4,977. Data is available for 2 years (2021–2022), covering 7 distinct procedure/service records.
Practice Information
- Specialty Primary Care
- Other Specialties General Practice
- Location Miami, FL
- Active Since 07/21/2021
- Last Updated 01/06/2022
- Taxonomy Code 261QP2300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457924003
Products in Payments
- REBYOTA (Biological) $245.09
- FARXIGA (Drug) $193.45
- JARDIANCE (Drug) $54.25
- MOUNJARO (Drug) $46.64
- XARELTO (Drug) $35.83
- Kerendia (Drug) $31.12
- AREXVY (Drug) $22.82
- Qutenza (Drug) $19.16
- Ozempic (Drug) $17.50
- AIRSUPRA (Drug) $14.27
- EMGALITY (Drug) $13.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Miami
Dr. Victor Martinez, Md, MD
Primary Care — Payments: $12,772
Dr. Maria Gadea, Arnp, ARNP
Primary Care — Payments: $4,178
Liliam Palacios
Primary Care — Payments: $3,440
Kelys Caballero Osorio, Md, MD
Primary Care — Payments: $3,341
Mr. Michael Hidalgo, Arnp, ARNP
Primary Care — Payments: $1,860
Christopher De La Paz, Aprn, APRN
Primary Care — Payments: $1,798